| IMMUNIC INC. DL-,0001 |
| USA |
| Gesundheit |
| US4525EP1011 / A2PHD4 |
| 10VA (Frankfurt) / IMUX (NASDAQ) |
| FRA:10VA, ETR:10VA, 10VA:GR, NASDAQ:IMUX |
| - |
| https://www.immunic-thera.. |
|
Immunic Inc. is a biotechnology company focused on developing pioneering therapies in the field of immunology. The company's primary aim is to create and advance oral therapies to treat severe and chr..
>Volltext.. |
| 88.18 Mio. EUR |
| 58.91 Mio. EUR |
| - |
| -88.78 Mio. EUR |
| -86.82 Mio. EUR |
| -0.73 EUR |
| 0.67 Mio. EUR |
| 29.6 Mio. EUR |
| -75.4 Mio. EUR |
| 1.17 |
| - |
| -0.9% |
| - |
| - |
| - |
| - |
| IMMUNIC |
| 15.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|